Actualización en el manejo del síndrome de ovario poliquístico durante la edad fértil

Abstract

Introduction: Polycystic ovary syndrome is one of the main endocrine disorders in women of childbearing age with a worldwide prevalence of around 20%, and characterized by hyperandrogenic manifestations, anovulatory periods and ovaries composed of multiple cysts detected ultrasonographically. Likewise, its relationship with metabolic alterations such as obesity and insulin resistance is well established. Although conventional treatment schemes have been instituted for this entity, alternative therapeutic routes have not been considered, which have demonstrated an equal or even superior effect in various parameters, and with significantly lower risks. Objective: Analyze the therapeutic approach that has been used in the conventional management of PCOS, as well as the latest findings regarding the use of medications and emerging practices through the study of recent research that will guide comprehensive and updated management of this pathology. Methodology: A documentary, observational, descriptive and retrospective study was carried out based on the review of information from the last 5 years available in indexed scientific journals, through the use of approved and reliable databases, such as PUBMED, Scielo and Scholar Google. Conclusions: This review showed that supplements such as myo-inositol and berberine are viable natural alternatives for conditions such as insulin resistance, with a therapeutic spectrum comparable to that of well-established drugs in the treatment of this disease, such as metformin, and with fewer reported digestive adverse effects.